Antibiotic reassessment is often organized around fixed review points, yet the information needed to modify treatment rarely matures simultaneously. Microbiological evidence may justify spectrum narrowing while the patient still requires intravenous therapy; clinical recovery may permit oral treatment while uncertainty about total duration remains; conversely, negative cultures may provide little reassurance when the host trajectory remains concerning. This For Debate article argues that antibiotic de-escalation is better understood as a set of time-linked but partly independent reassessment processes. Diagnostic evidence, host trajectory, spectrum, route, dose or exposure, and duration should each be reconsidered whenever their relevant evidence changes, without assuming that improvement in one dimension automatically justifies movement in another. The proposed “clock” is therefore not a universal timetable. It is a way to make asynchronous treatment decisions explicit while preserving infection site, pathogen, source control, immune status, severity, pharmacokinetics and pharmacodynamics as determinants of when each modification becomes defensible.
